Daniel Grosslight
Stock Analyst at Citigroup
(1.05)
# 3,808
Out of 4,996 analysts
103
Total ratings
32.26%
Success rate
-15.46%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MCK McKesson | Maintains: Buy | $820 → $860 | $760.55 | +13.08% | 8 | Sep 24, 2025 | |
OMI Owens & Minor | Maintains: Buy | $11 → $7 | $4.77 | +46.75% | 7 | Aug 12, 2025 | |
HCAT Health Catalyst | Downgrades: Neutral | $6.5 → $3.5 | $2.80 | +25.00% | 10 | Aug 8, 2025 | |
AGL agilon health | Downgrades: Neutral | $3 → $1 | $1.09 | -8.26% | 6 | Aug 6, 2025 | |
WAY Waystar Holding | Initiates: Buy | $45 | $37.56 | +19.81% | 1 | Jun 25, 2025 | |
CAH Cardinal Health | Maintains: Neutral | $157 → $170 | $153.71 | +10.60% | 9 | Jun 13, 2025 | |
HIMS Hims & Hers Health | Maintains: Sell | $25 → $30 | $58.40 | -48.63% | 11 | May 6, 2025 | |
TDOC Teladoc Health | Maintains: Neutral | $11 → $8.75 | $8.16 | +7.23% | 11 | Apr 25, 2025 | |
EVH Evolent Health | Maintains: Buy | $21 → $18 | $8.95 | +101.12% | 4 | Jan 10, 2025 | |
GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $4.04 | +54.70% | 7 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $23.62 | +48.18% | 6 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $23.98 | +4.25% | 1 | Apr 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $3.94 | +153.81% | 7 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $12.04 | -33.55% | 7 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $2.03 | -38.42% | 5 | Apr 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $2.78 | +25.90% | 2 | Nov 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $8.89 | +46.23% | 1 | Dec 11, 2019 |
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $820 → $860
Current: $760.55
Upside: +13.08%
Owens & Minor
Aug 12, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $4.77
Upside: +46.75%
Health Catalyst
Aug 8, 2025
Downgrades: Neutral
Price Target: $6.5 → $3.5
Current: $2.80
Upside: +25.00%
agilon health
Aug 6, 2025
Downgrades: Neutral
Price Target: $3 → $1
Current: $1.09
Upside: -8.26%
Waystar Holding
Jun 25, 2025
Initiates: Buy
Price Target: $45
Current: $37.56
Upside: +19.81%
Cardinal Health
Jun 13, 2025
Maintains: Neutral
Price Target: $157 → $170
Current: $153.71
Upside: +10.60%
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $58.40
Upside: -48.63%
Teladoc Health
Apr 25, 2025
Maintains: Neutral
Price Target: $11 → $8.75
Current: $8.16
Upside: +7.23%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $8.95
Upside: +101.12%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $4.04
Upside: +54.70%
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $23.62
Upside: +48.18%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $23.98
Upside: +4.25%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $3.94
Upside: +153.81%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $12.04
Upside: -33.55%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $2.03
Upside: -38.42%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $2.78
Upside: +25.90%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $8.89
Upside: +46.23%